Commission Implementing Regulation (EU) 2025/2154 of 17 October 2025 laying down good manufacturing practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Article 21Documentation system
In force · version of Nov 16, 2025
1.A documentation system that is adequate to achieve the objectives of the quality management system shall be established and maintained.
2.The documentation system shall cover in a comprehensive manner the instructions and specifications related to the manufacture of active substances and intermediates thereof, as well as other documentation relevant to the quality management system and shall ensure that records are made of the activities which may directly or indirectly affect the quality of the active substances or intermediates thereof. The documentation system shall specify the retention period for each of the documents or records.
3.All production, control, and distribution records of a batch shall be retained for at least 1 year after the expiry date of the batch.
4.By derogation from paragraph 3, records for active substances with retest dates shall be retained for at least 3 years after the batch is completely distributed.
5.The content of documents shall be unambiguous and be kept up to date.
6.Documentation may be kept in a variety of forms and the requirements set out in this Chapter are applicable irrespective of form. Where electronic, photographic media, video recording or other data processing systems are used, the relevant systems shall be validated first to ensure that such systems are adequate to appropriately store the data during the required period of storage.
7.Suitable retrieval equipment and a means to produce hard copies shall be readily available in case reduction techniques such as microfilming or electronic records are used to retain specifications, instructions, procedures or records.
8.During the retention period, the documents and records shall be readily available at the establishment where the activities described in those documents and records occurred.
9.Electronic signatures on the documents and records shall be authenticated and secure.